Doxazosin
NDC 71610-927, doxazosin, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-927
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA019668
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-927 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXAZOSIN MESYLATE4 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-927-53 | 71610092753 | 60 TABLET in 1 BOTTLE (71610-927-53) |
| 71610-927-60 | 71610092760 | 90 TABLET in 1 BOTTLE (71610-927-60) |
| 71610-927-80 | 71610092780 | 180 TABLET in 1 BOTTLE (71610-927-80) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3ab222b7-74cc-5343-e063-6294a90a9616
Use it
Look up 71610-927 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-927 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-927. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.